Laporan Laba Rugi (TTM)
Laporan Laba Rugi Ultragenyx Pharmaceutical Inc. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 215 | 271 | 334 | 359 | 360 | 351 | 332 | 334 | 343 | 363 | 384 | 403 | 410 | 434 | 443 | 481 | 523 | 560 | 591 | 610 |
| Change (%) | 26.01 | 23.28 | 7.56 | 0.05 | -2.27 | -5.54 | 0.71 | 2.71 | 5.81 | 5.66 | 4.94 | 1.82 | 5.86 | 1.92 | 8.75 | 8.61 | 7.17 | 5.44 | 3.30 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 370 | 418 | 461 | 495 | 523 | 513 | 510 | 556 | 685 | 734 | 745 | 775 | 679 | 694 | 712 | 720 | 720 | 775 | 773 | 778 |
| Change (%) | 13.09 | 10.34 | 7.33 | 5.64 | -1.92 | -0.67 | 9.11 | 23.08 | 7.25 | 1.44 | 4.05 | -12.37 | 2.15 | 2.60 | 1.11 | 0.10 | 7.53 | -0.20 | 0.64 | |
| % of Revenue | 171.94 | 154.31 | 138.11 | 137.82 | 145.52 | 146.03 | 153.55 | 166.36 | 199.35 | 202.05 | 193.98 | 192.34 | 165.54 | 159.74 | 160.81 | 149.52 | 137.80 | 138.26 | 130.87 | 127.50 |
| Gross Operating Profit | -155 | -147 | -127 | -136 | -164 | -162 | -178 | -222 | -341 | -371 | -361 | -354 | 201 | -259 | -269 | -238 | -198 | -214 | -182 | -168 |
| Change (%) | -4.87 | -13.48 | 6.72 | 20.42 | -1.16 | 9.90 | 24.80 | 53.77 | 8.69 | -2.69 | -1.91 | -156.77 | -229.11 | 3.75 | -11.44 | -17.10 | 8.49 | -14.95 | -7.96 | |
| % of Revenue | -71.94 | -54.31 | -38.11 | -37.82 | -45.52 | -46.03 | -53.55 | -66.36 | -99.35 | -102.05 | -93.98 | -87.85 | 48.98 | -59.74 | -60.81 | -49.52 | -37.80 | -38.26 | -30.87 | -27.50 |
| SG&A | 174 | 183 | 189 | 200 | 212 | 220 | 234 | 249 | 265 | 278 | 287 | 301 | 306 | 310 | 311 | 311 | 316 | 322 | 331 | 337 |
| Change (%) | 5.27 | 3.14 | 5.91 | 5.88 | 3.96 | 6.39 | 6.29 | 6.41 | 5.07 | 3.36 | 4.61 | 1.69 | 1.30 | 0.49 | -0.26 | 1.75 | 1.79 | 3.00 | 1.82 | |
| % of Revenue | 80.79 | 67.50 | 56.47 | 55.60 | 58.85 | 62.60 | 70.50 | 74.41 | 77.09 | 76.55 | 74.88 | 74.65 | 74.55 | 71.34 | 70.34 | 64.52 | 60.44 | 57.41 | 56.08 | 55.28 |
| R&D | 18 | 18 | 488 | 22 | ||||||||||||||||
| Change (%) | 0.00 | 2,592.56 | ||||||||||||||||||
| % of Revenue | 4.72 | 4.50 | 118.94 | 4.25 | ||||||||||||||||
| OpEx | 544 | 601 | 650 | 695 | 735 | 733 | 744 | 805 | 949 | 1,012 | 1,050 | 1,076 | 1,003 | 1,003 | 1,023 | 1,030 | 1,058 | 1,096 | 1,104 | 1,115 |
| Change (%) | 10.59 | 8.15 | 6.92 | 5.71 | -0.23 | 1.45 | 8.23 | 17.93 | 6.64 | 3.76 | 2.41 | -6.75 | 0.05 | 1.95 | 0.70 | 2.75 | 3.56 | 0.73 | 1.00 | |
| % of Revenue | 252.73 | 221.80 | 194.58 | 193.42 | 204.37 | 208.63 | 224.06 | 240.77 | 276.44 | 278.60 | 273.59 | 267.00 | 244.51 | 231.08 | 231.15 | 214.04 | 202.49 | 195.67 | 186.94 | 182.78 |
| Operating Income | -328 | -330 | -316 | -336 | -375 | -382 | -412 | -471 | -606 | -649 | -666 | -673 | -593 | -569 | -580 | -549 | -536 | -536 | -514 | -505 |
| Change (%) | 0.50 | -4.27 | 6.24 | 11.77 | 1.73 | 7.88 | 14.28 | 28.74 | 7.11 | 2.69 | 0.95 | -11.89 | -3.98 | 1.98 | -5.44 | -2.39 | 0.04 | -4.18 | -1.65 | |
| % of Revenue | -152.73 | -121.80 | -94.58 | -93.42 | -104.37 | -108.63 | -124.06 | -140.77 | -176.44 | -178.60 | -173.59 | -167.00 | -144.51 | -131.08 | -131.15 | -114.04 | -102.49 | -95.67 | -86.94 | -82.78 |
| Interest Expense | -26 | -33 | -34 | -34 | -34 | -29 | -28 | -25 | -31 | -43 | -52 | -61 | -65 | -66 | -66 | -67 | -65 | -63 | -62 | -60 |
| Change (%) | 26.93 | 1.01 | 0.26 | 0.30 | -12.99 | -6.23 | -8.94 | 23.17 | 39.00 | 21.04 | 17.91 | 5.15 | 2.25 | 0.32 | 0.88 | -2.92 | -2.79 | -2.39 | -3.12 | |
| % of Revenue | -12.19 | -12.28 | -10.06 | -9.38 | -9.40 | -8.37 | -8.31 | -7.51 | -9.01 | -11.84 | -13.56 | -15.24 | -15.74 | -15.20 | -14.96 | -13.88 | -12.41 | -11.25 | -10.42 | -9.77 |
| Net Income | -256 | -187 | -204 | -351 | -356 | -454 | -470 | -506 | -678 | -707 | -719 | -721 | -635 | -607 | -613 | -585 | -559 | -569 | -550 | -533 |
| Change (%) | -27.22 | 9.17 | 72.54 | 1.18 | 27.69 | 3.56 | 7.60 | 34.02 | 4.33 | 1.65 | 0.23 | -11.86 | -4.51 | 1.11 | -4.60 | -4.47 | 1.82 | -3.44 | -3.03 | |
| % of Revenue | -119.19 | -68.84 | -60.96 | -97.79 | -98.89 | -129.20 | -141.65 | -151.34 | -197.47 | -194.71 | -187.31 | -178.91 | -154.87 | -139.70 | -138.58 | -121.57 | -106.93 | -101.60 | -93.04 | -87.34 |
Source: Capital IQ
